Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment
Top Ten Searches
rheumatoid arthritis lupus polymyalgia sjogrens fibromyalgia amyloidosis vasculitis urate raynauds myositisYour Article Summary
Stigmasterol: a phytosterol with potential anti-osteoarthritic properties
Osteoarthritis and Cartilage , 09/18/09
Gabay O et al. – Stigmasterol inhibits several pro-inflammatory and matrix degradation mediators typically involved in OA-induced cartilage degradation, at least in part through the inhibition of the NF-kappa B pathway.
Methods- A model of newborn mouse chondrocytes and human OA chondrocytes in primary culture stimulated with or without IL1beta (10ng/ml), for 18 h was used
- Cells were pre-incubated for 48 h with stigmasterol (20 ?g/ml) compared to untreated cells
- The presence of stigmasterol in chondrocyte, compared to other phytosterols was studied
- The role of stigmasterol on the expression of various genes involved in inflammation (IL-6) and cartilage turn-over (MMP-3,-13, ADAMTS -4, -5, type II collagen, aggrecan) by quantitative RT-PCR was assessed
- Additional experiments were carried out to monitor the production of MMP-3 and PGE2 by specific immuno-enzymatic assays
- The role of stigmasterol on NF-kappaB activation by western blot, using an anti- I?B? antibody
- After 18 h of IL-1? treatment, MMP-3, MMP-13, ADAMTS-4, but not ADAMTS-5 RNA expression were elevated, as well as MMP-3 and PGE2 protein levels in mouse and human chondrocytes
- Type II collagen and aggrecan mRNA levels were significatively reduced
- Pre-incubation of stigmasterol to IL1-beta-treated cells significantly decreased these effects described above (significant reduction of MMP-3 mRNA in human and mouse, MMP-3 protein in mouse, MMP-13 mRNA in mouse and human, ADAMTS-4 mRNA in human, PGE2 protein in human and mouse) Finally, stigmasterol was capable of counteracting the IL-1beta-induced NF-kappa B pathway
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Osteonecrosis of the jaw correlated to bisphosphonate therapy in non-oncologic patients: Clinicopathological features of 24 patients
Journal of Rheumatology, 11/09/09
Treatment of polymyalgia rheumatica
Archives of Internal Medicine, 11/10/09
Osteoarthritis: A review of treatment options
Geriatrics, 10/21/09
Today in Osteoarthritis...keeping you current
Receive free subspecialty "5-minute updates" via email
Osteoarthritis: A review of treatment options
Geriatrics, 10/21/09
Doxycycline for osteoarthritis of the knee or hip
Cochrane Reviews, 10/23/09
Effect of biomagnetic therapy versus physiotherapy for treatment of knee osteoarthritis: A randomized controlled trial
Journal of Rehabilitation Medicine, 11/20/09
Sponsor
Article Search
Sponsor


See Latest Articles


